Skip to Content
Merck
All Photos(1)

Documents

11966006001

Roche

TUNEL Dilution Buffer

pH 7.2-7.4 (20 °C), suitable for detection, pkg of 2 × 10 mL

Synonym(s):

TUNEL, transferase dUTP nick end labeling

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41116100

packaging

pkg of 2 × 10 mL

manufacturer/tradename

Roche

pH

7.2-7.4 (20 °C)

application(s)

detection

storage temp.

2-8°C

General description

The TUNEL dilution buffer can be used in combination with the in-situ cell death detection kits. It can be used to dilute terminal deoxynucleotidyl transferase (TdT) for the TUNEL reaction in special applications and also to label DNA strand breaks for detecting and quantitating apoptotic cell death at the single-cell level in cells and tissues.

Application

TUNEL Dilution Buffer has been used:
  • to dilute terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) enzyme (TdT) in preparing TUNEL reaction mixture for TUNEL critical commercial assays
  • to quantify apoptosis in rat kidney
  • to dilute the terminal deoxynucleotidyl transferase enzyme solution to identify DNA fragmentation in oligodendrocytes in vitro
  • for TUNEL assays

TUNEL dilution buffer has been used in terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) assays.

Preparation Note

Working concentration: Working concentration of conjugate depends on application and substrate.


The following concentrations should be taken as a guideline:
  • ELISA: 100 mU/ml
  • Western blot: 100mU/ml


Storage conditions (working solution): Dilutions of TdT should be prepared immediately before use and should not be stored.
Keep TUNEL reaction mixture on ice until use.

Other Notes

For life science research only. Not for use in diagnostic procedures.

Pictograms

Health hazard

Signal Word

Danger

Hazard Statements

Hazard Classifications

Aquatic Chronic 3 - Carc. 1B Inhalation

Storage Class Code

6.1D - Non-combustible acute toxic Cat.3 / toxic hazardous materials or hazardous materials causing chronic effects

WGK

WGK 2

Flash Point(F)

does not flash

Flash Point(C)

does not flash


Certificates of Analysis (COA)

Search for Certificates of Analysis (COA) by entering the products Lot/Batch Number. Lot and Batch Numbers can be found on a product’s label following the words ‘Lot’ or ‘Batch’.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Customers Also Viewed

Yoshiki Hayashi et al.
Proceedings of the National Academy of Sciences of the United States of America, 101(28), 10338-10342 (2004-07-09)
Nanos (Nos) is one of the evolutionarily conserved proteins known to direct germ-line development. In Drosophila, maternal Nos protein maintains transcriptional quiescence in the germ-line progenitors or pole cells to repress ectopic expression of somatic genes. Here we show that
Preclinical characterization of abemaciclib in hormone receptor positive breast cancer.
Torres-Guzman R, et al.
Oncotarget, 8(41), 69493-69493 (2017)
Jiarui Han et al.
Drug design, development and therapy, 14, 3223-3234 (2020-08-28)
Inflammation-induced podocyte apoptosis plays an important role in kidney injury during diabetic nephropathy (DN). Hirudin (HIR), a natural compound extracted from leeches, can inhibit inflammation. However, whether HIR can protect the kidneys against inflammation during DN is unknown. In the
Anna Lm Smith et al.
Nature cancer, 1(10), 976-989 (2020-10-20)
Oxidative phosphorylation (OXPHOS) defects caused by somatic mitochondrial DNA (mtDNA) mutations increase with age in human colorectal epithelium and are prevalent in colorectal tumours, but whether they actively contribute to tumorigenesis remains unknown. Here we demonstrate that mtDNA mutations causing
Raquel Torres-Guzmán et al.
Oncotarget, 8(41), 69493-69507 (2017-10-21)
Abemaciclib is an ATP-competitive, reversible kinase inhibitor selective for CDK4 and CDK6 that has shown antitumor activity as a single agent in hormone receptor positive (HR+) metastatic breast cancer in clinical trials. Here, we examined the mechanistic effects of abemaciclib

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service